Search for: "State v. Bristol-Myers Squibb Co." Results 81 - 100 of 189
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Apr 2015, 2:00 am
We reported to you last August on Bristol-Myers Squibb Co. v. [read post]
3 Mar 2012, 5:36 pm by Schachtman
Bristol-Myers Squibb Co., 1998 WL 812318 (M.D. [read post]
2 Jan 2007, 12:08 pm
Bristol-Myers Squibb Co., 19 F.3d 1418, 1424, 30 USPQ2d 1285, 1290 (Fed. [read post]
17 Feb 2017, 12:21 pm by Amy Howe
Bristol-Myers Squibb Co. v. [read post]
20 Nov 2011, 10:31 pm by Victoria VanBuren
The court’s distinction is not a commercial one—and I would have thought that it would by now have been safely relegated to the dustbin of obsolete and antiquated notions; see Bristol-Myers Squibb Co. v. [read post]
11 Oct 2010, 12:59 pm by FDABlog HPM
Since our last post, many more complaints have been filed alleging false marking by various parties in the FDA-regulated industry, including Ranbaxy, Roche Diagnostics Corporation, Walgreens, Bristol-Myers Squibb, Eisai, Takeda, Watson, and many, many  others. [read post]
4 Oct 2019, 10:55 am by Robert Whitman and Hillary Massey
  Noting that the First Circuit has not addressed the question, the court described two divergent approaches taken by district courts around the country on the personal jurisdiction issue:  some courts, with which the Chavira court agreed, have ruled that the Supreme Court’s decision in Bristol-Myers Squibb Co. v. [read post]
25 Nov 2012, 1:00 pm
Under  Bristol-Myers Squibb v Paranova condition ("the BMS conditions"), Condition 5 requires the importer to give notice to the trade mark owner before any repackaged product is put on sale, and, on demand, supplies him with a specimen. [read post]
10 Jun 2009, 10:00 pm
Bristol-Myers Squibb Co., 2003 WL 22425009, at *6 n.3 (N.D. [read post]
9 Nov 2017, 4:00 am by Alan Macek
Earlier this year, the Federal Court of Appeal, in Bristol-Myers Squibb Canada Co. v. [read post]